ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Sanofi to expand plant in Belgium

by Ann M. Thayer
April 25, 2016 | APPEARED IN VOLUME 94, ISSUE 17

Sanofi will spend $340 million to expand its biologics production site in Geel, Belgium. The French drug company already makes active ingredients for enzyme replacement therapies there. Additional capacity along with new process and quality control labs will support Sanofi’s monoclonal antibody development pipeline. Sanofi and its Genzyme biologics business have already invested $680 million at the 15-year-old site.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment